Traitement du cancer : progrès réels entre 2017 et 2022
| dc.contributor.advisor | Younes Rahhali | |
| dc.contributor.author | Nejma Salla Abdou | |
| dc.date.accessioned | 2023-09-15T13:42:54Z | |
| dc.date.accessioned | 2026-01-22T13:34:50Z | |
| dc.date.available | 2023-09-15T13:42:54Z | |
| dc.date.issued | 2023 | |
| dc.description.collaborator | Yassir Bousliman | |
| dc.description.collaborator | Rachid Tanz | |
| dc.description.collaborator | Mustapha Bouatia | |
| dc.description.collaborator | Sanaa Makram | |
| dc.identifier.uri | https://toubkalpreprod.imist.ma/handle/123456789/19354 | |
| dc.language.iso | fr | |
| dc.publisher | Université Mohammed 5 de Rabat, Faculté de Médecine et de Pharmacie, Rabat | fr_FR |
| dc.subject | Cancer | fr_FR |
| dc.subject | Actualité | fr_FR |
| dc.subject | Radiothérapie | fr_FR |
| dc.subject | Chimiothérapie | fr_FR |
| dc.subject | Immunothérapie | fr_FR |
| dc.subject | Thérapies Ciblées | fr_FR |
| dc.subject.other | Sciences médicales | |
| dc.subject.specific | Thérapeutique | |
| dc.title | Traitement du cancer : progrès réels entre 2017 et 2022 | fr_FR |
Files
Original bundle
1 - 1 of 1